Authors


Malley, MD, MPH

Latest:

Patients' Perspectives of Care Management: A Qualitative Study

Risk-stratified care management is a cornerstone of patient-centered medical home models, but studies on patients’ perspectives of it are scarce. We explored patients’ experiences with care management, what they found useful, and what needs improvement.





Winston F. Wong, MD

Latest:

Medication Use, Emergency Hospital Care Utilization, and Quality-of-Life Outcome Disparities by Race/Ethnicity Among Adults With Asthma

African Americans had more asthma-specific emergency care utilization, and African Americans and Native Americans/Aleutians/Eskimos were more likely to report lower asthma-specific quality-of-life scores, than whites.




William Parsons, MS

Latest:

Are Benefits From Diabetes Self-Management Education Sustained?

Conventional individualized diabetes self-management education resulted in sustained improvement in self-efficacy and diabetes distress. Short-term improvements in A1C, nutrition, and physical activity were not sustained.


Carolyn Cannuscio, ScD

Latest:

Addressing Cost Barriers to Medications: A Survey of Patients Requesting Financial Assistance

Patients are receptive to diverse strategies to screen for cost barriers but want participatory decision making to address cost-efficacy tradeoffs.




Brendan M. Weiss, MD

Latest:

High Cost Sharing and Specialty Drug Initiation Under Medicare Part D: A Case Study in Patients With Newly Diagnosed Chronic Myeloid Leukemia

A Medicare claims analysis of patients newly diagnosed with chronic myeloid leukemia revealed that high cost sharing was associated with reduced and/or delayed tyrosine kinase inhibitor initiation under Part D.


Patrick Monahan, MD

Latest:

There's More Than One Way to Build a Medical Home

Even among practices reaching the highest level of PCMH achievement, there are variations in the implementation of key medical home capabilities.


Ronald T. Ackermann, MD

Latest:

Medical Costs Associated With Type 2 Diabetes Complications and Comorbidities

A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.




Deirdre A. Shires, MPH, MSW

Latest:

Colorectal Cancer Screening Use Among Insured Primary Care Patients

Colorectal cancer screening use was similar in 2 divergent primary care populations. Colonoscopy was the most frequently used modality; FOBT was used inconsistently.


Taylor Tinkham Schwartz, MPH

Latest:

The Social Value of Childhood Vaccination in the United States

Vaccination of children born in the United States in 2009 will save 1.2 million quality-adjusted life-years, generating $184 billion in social value net of vaccination costs.


J.F. Philip Merrigan, PhD

Latest:

Claims-Based Risk Model for First Severe COPD Exacerbation

A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.


Janel Hanmer, MD, PhD

Latest:

A Scoping Review of US Insurers’ Use of Patient-Reported Outcomes

This scoping review found 350 articles that discuss US health insurance providers’ use of patient-reported outcomes about health-related quality of life.



Laurence S. Magder, PhD

Latest:

Impact of Formulary Restrictions on Medication Use and Costs

Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, and antihypertension medications among low-income subsidy recipients in Medicare Part D plans.


Heli Halava, MD

Latest:

Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide Study

One-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.


Adam S. Wilk, PhD

Latest:

Medicaid Managed Care Network Adequacy Standards and Mental Health Care Access

Quantitative Medicaid managed care network adequacy standards were not associated with improved mental health (MH) care access among adults and those with MH conditions.


Christopher S. Kim, MD, MBA

Latest:

Excess Hospitalization Days in an Academic Medical Center: Perceptions of Hospitalists and Discharge Planners

We assessed the frequency of and reasons for medically unnecessary hospital days, which affect patients, payers, hospitals, and healthcare providers.


Sharon Pearce

Latest:

Palliative Care for Patients With Advanced Illness: A Changing Policy Landscape

A lag in policy changes has resulted in significant variation across palliative care programs for treating advanced illnesses. A recent shift in policy has, however, allowed small-scale testing of community-based palliative care delivery and some innovations in other delivery systems.


Joshua P. Cohen, PhD

Latest:

Complying With State and Federal Regulations on Essential Drug Benefits: Implementing the Affordable Care Act

Essential health benefits form a cornerstone of the Affordable Care Act. Our study shows that health plans in California and Massachusetts are not fully compliant with state and federal regulations on essential drug benefits.


Bryce B. Reeve, PhD

Latest:

The Need for a Serious Illness Digital Ecosystem (SIDE) to Improve Outcomes for Patients Receiving Palliative and Hospice Care

Palliative and hospice care services produce well-known benefits for patients living with serious illness and for their families. Benefits include improved quality of life and reduced symptom burden, spiritual and emotional distress, and caregiver distress.



Elena Tragni, PhD

Latest:

Assessment and Potential Determinants of Compliance and Persistence to Antiosteoporosis Therapy in Italy

This analysis of antiosteoporosis therapy shows that 75% of patients have inadequate drug coverage and that adherence is strongly associated with age and administration regimen.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo